Correction to: Combined taurine, epigallocatechin gallate and genistein therapy reduces HSC-T6 Cell proliferation and modulates the expression of fibrogenic factors (Int. J. Mol. Sci. 2013, 14, 20543-20554)

1Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

Abstract

The authors regret that, during the preparation of our published manuscript “Combined taurine, epigallocatechin gallate and genistein therapy reduces HSC-T6 cell proliferation and modulates the expression of fibrogenic factors” [1], we submitted an incorrect version of Figure 2. Thus, Figure 2 should be replaced with the following figure (Figure 1). The correction does not change the scientific conclusions of the article in any way. The authors apologize for any confusion this error may have caused to the readers.

Cite

CITATION STYLE

APA

Li, Y., Luo, Y., Zhang, X., Lin, X., He, M., & Liao, M. (2021, March 1). Correction to: Combined taurine, epigallocatechin gallate and genistein therapy reduces HSC-T6 Cell proliferation and modulates the expression of fibrogenic factors (Int. J. Mol. Sci. 2013, 14, 20543-20554). International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms22052343

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free